We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×

Exploring ACSL4/LPCAT3/ALOX15 and SLC7A11/GPX4/NFE2L2 as potential targets in ferroptosis-based cancer therapy

    Gaurav Gupta

    *Author for correspondence:

    E-mail Address: gauravpharma25@gmail.com

    School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India

    Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Science, Chennai, India

    ,
    Asif Ahmad Bhat

    School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India

    ,
    Ahsas Goyal

    Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India

    ,
    Neelam Singla

    School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India

    ,
    Saurabh Gupta

    Department of Pharmacology, Chameli Devi Institute of Pharmacy, Khandwa Road, Village Umrikheda, Near Toll Booth, Indore, Madhya Pradesh, 452020, India

    ,
    Sanjay Sharma

    Shri Vile Parle Kelavani Mandal's Narsee Monjee Institute of Management Studies, Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, Vile Parle West, Mumbai, Maharashtra, India

    ,
    Shvetank Bhatt

    School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune-411038, Maharashtra, India

    &
    Kamal Dua

    Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, New South Wales, 2007, Australia

    Faculty of Health, Australian Research Center in Complementary & Integrative Medicine, University of Technology, Sydney, New South Wales, 2007, Australia

    Published Online:https://doi.org/10.4155/fmc-2023-0125
    Free first page

    References

    • 1. Chen P, Wu Q, Feng J et al. Erianin, a novel dibenzyl compound in dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis. Signal Transduct. Target. Ther. 5(1), 51 (2020).
    • 2. Fang X, Ardehali H, Min J, Wang F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat. Rev. Cardiol. 20(1), 7–23 (2023).
    • 3. Gao M, Yi J, Zhu J et al. Role of mitochondria in ferroptosis. Mol. Cell 73(2), 354–363.e3 (2019).
    • 4. Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell 35(6), 830–849 (2019).
    • 5. Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12(8), 599–620 (2021).
    • 6. Kremer DM, Nelson BS, Lin L et al. GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis. Nat. Commun. 12(1), 4860 (2021).
    • 7. Li S, He Y, Chen K et al. RSL3 drives ferroptosis through NF-κB pathway activation and GPX4 depletion in glioblastoma. Oxid. Med. Cell. Longev. 2021, 2915019 (2021).
    • 8. Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol. Cell 82(12), 2215–2227 (2022).
    • 9. Liu J, Kuang F, Kroemer G, Klionsky DJ, Kang R, Tang D. Autophagy-dependent ferroptosis: machinery and regulation. Cell Chem. Biol. 27(4), 420–435 (2020).
    • 10. Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol. Cancer 21(1), 47 (2022).
    • 11. Liu J, Zhang C, Wang J, Hu W, Feng Z. The regulation of ferroptosis by tumor suppressor p53 and its pathway. Int. J. Mol. Sci. 21(21), 8387 (2020).
    • 12. Shen M, Li Y, Wang Y et al. N(6)-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells. Redox Biol. 47, 102151 (2021).
    • 13. Yu H, Yang C, Jian L et al. Sulfasalazine–induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor. Oncol. Rep. 42(2), 826–838 (2019).
    • 14. Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat. Rev. Clin. Oncol. 18(5), 280–296 (2021).
    • 15. You JH, Lee J, Roh JL. PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells. J. Exp. Clin. Cancer Res. 40(1), 350 (2021).
    • 16. Fu D, Wang C, Yu L, Yu R. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling. Cell. Mol. Biol. Lett. 26(1), 26 (2021).
    • 17. Zhang H, Deng T, Liu R et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol. Cancer 19(1), 43 (2020).
    • 18. Wang Y, Wei Z, Pan K, Li J, Chen Q. The function and mechanism of ferroptosis in cancer. Apoptosis 25(11–12), 786–798 (2020).
    • 19. Mou Y, Wang J, Wu J et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J. Hematol. Oncol. 12(1), 34 (2019).